Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
11.79
+0.08 (0.68%)
Apr 9, 2026, 3:58 PM EST
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $46.49 billion as of April 10, 2026. Its market cap has increased by 92.57% in one year.
Market Cap
46.49B
Enterprise Value
81.40B
Revenue
53.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
$11.79
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 46.49B, an increase of 693.34%. That is a compound annual growth rate of 6.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 46.49B | 8.69% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 748.06M |
| Glass House Brands | 725.95M |
| Elite Pharmaceuticals | 409.26M |
| Nika Pharmaceuticals | 398.45M |
| CytoDyn | 347.32M |
| Northwest Biotherapeutics | 328.63M |
| Silence Therapeutics | 273.96M |
| American Oncology Network | 266.48M |